Position in AZN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,503,720
+$3,859,300 QoQ
Shares Held
29,025
+248.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#385
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Campbell & CO Investment Adviser LLC holds $29,426,907 across 9 Drug Manufacturers - General names. AZN ranks #2 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
18,379 | $6,655,403 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
29,025 | $5,503,720 | |
| 3 | LLY |
ELI LILLY & Co
|
3,682 | $4,416,301 | |
| 4 | GSK |
GSK plc
|
83,989 | $4,402,703 | |
| 5 | SNY |
Sanofi
|
52,949 | $2,258,804 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,781 | $2,246,451 | |
| 7 | PFE |
Pfizer Inc
|
75,099 | $1,808,383 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
23,327 | $1,344,101 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,503,720 | 29,025 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,644,420 | 8,338 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||